Translational Neuroendocrinology
31 – 40 of 127
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Thermoregulatory disorders in Huntington disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Thermoregulation in amyotrophic lateral sclerosis
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(37). p.8765-8774(
- Contribution to journal › Article
-
Mark
mHTT Seeding Activity : A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease
(
- Contribution to journal › Article
- 2017
-
Mark
Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis
(
- Contribution to journal › Article
-
Mark
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Microstructure alterations in the hypothalamus in cranially radiated childhood leukaemia survivors but not in craniopharyngioma patients unaffected by hypothalamic damage
(
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Ethical aspects of a predictive test for Huntington's Disease: A long term perspective.
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article